Scientists continue to investigate how cannabinoids may interact with the immune system, especially in conditions involving chronic inflammation and autoimmune responses. In the review “Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges,” researchers examined how cannabinoids may influence immune pathways connected to autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, lupus, and type 1 […]
Category: CBC
How Minor Cannabinoids (CBG, CBD, CBN & CBC) May Support Sensory Nerve Function (Pub. April 2026)
Researchers continue to explore how hemp-derived cannabinoids interact with the body’s nervous system, and a recent study examined how CBD, CBG, CBN, and CBC affect sensory neuron activation. Sensory neurons help the body process signals related to discomfort, temperature, and inflammation. The study found that each cannabinoid influenced these nerve cells differently, suggesting that cannabinoids […]
Non-Psychotropic Cannabinoids Continue Showing Promise in Neuroinflammation Research (Pub. April 2026)
Scientists continue studying how hemp-derived cannabinoids may support the body’s response to neuroinflammation and neurodegenerative conditions. In the review “Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration,” researchers examined how cannabinoids such as CBD, CBG, and CBC interact with microglia — the immune cells of the central nervous […]